Immuneering Corp
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | – | – | – | – | – | 100.0% | – | – | – | – | – | 100.0% | 100.0% | |
| 52.8% | 49.3% | 46.1% | 71.2% | 54.7% | 48.3% | 45.4% | 108.8% | 49.5% | 265.1% | 50.4% | 34,717,335.8% | – | 0.2% | – | – | – | – | – | 24.0% | – | – | – | – | – | 50.0% | 293.6% | |
| 47.2% | 50.7% | 53.9% | 28.8% | 45.3% | 51.7% | 54.6% | -8.8% | 50.5% | -165.1% | 49.6% | 100.0% | – | -0.2% | – | – | – | – | – | -24.0% | – | – | – | – | – | 50.0% | -193.6% | |
| 584.5% | 669.9% | 596.1% | 735.3% | 720.5% | 1,059.3% | 1,287.5% | 4,193.5% | 4,931.2% | 8,411.5% | 24,397.7% | 2,169,617.8% | – | 10.0% | – | – | – | – | – | 2,037.1% | – | – | – | – | – | 3,877.6% | 2,958,627.1% | |
| 133.3% | 130.9% | 102.4% | 171.1% | 158.2% | 203.0% | 539.1% | 1,660.8% | 2,151.4% | 3,922.9% | 9,994.8% | 902,637.4% | – | 4.3% | – | – | – | – | – | 508.6% | – | – | – | – | – | 1,384.2% | 1,301,122.6% | |
| 717.8% | 800.8% | 698.5% | 906.4% | 878.8% | 1,262.4% | 1,826.6% | 5,854.2% | 7,086.9% | 12,169.3% | 34,411.6% | 3,073,727.9% | – | 14.1% | – | – | – | – | – | 2,531.0% | – | – | – | – | – | 5,263.9% | 17,363.7% | |
| -670.6% | -750.1% | -644.7% | -877.6% | -833.5% | -1,210.7% | -1,772.0% | -5,863.0% | -7,036.4% | -12,334.4% | -34,362.0% | -3,073,627.9% | – | -14.3% | – | – | – | – | – | -2,555.1% | – | – | – | – | – | -5,263.9% | -17,583.4% | |
| 8.0% | 0.5% | 0.2% | 0.1% | 0.8% | 0.5% | 3.6% | 1,880.1% | 72.1% | 151.2% | 581.0% | 113,443.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -662.6% | -749.6% | -644.5% | -877.5% | -832.6% | -1,210.1% | -1,770.1% | -5,850.4% | -7,020.5% | -12,208.7% | -33,466.1% | -2,911,247.5% | – | -12.9% | – | – | – | – | – | -2,485.3% | – | – | – | – | – | -4,784.6% | -15,867.7% | |
| – | 0.2% | -0.1% | 6.4% | – | 0.1% | -3.6% | -162.2% | -16.0% | -55.5% | -895.7% | -162,650.5% | – | -1.2% | – | – | – | – | – | 0.0% | – | – | – | – | – | – | – | |
| -662.6% | -749.6% | -644.5% | -877.5% | -832.6% | -1,210.2% | -1,770.1% | -5,688.2% | -7,020.4% | -12,208.7% | -33,466.2% | -2,911,112.3% | – | -12.9% | – | – | – | – | – | -2,485.3% | – | – | – | – | – | -4,784.6% | -15,867.8% | |
| -667.4% | -748.8% | -643.8% | -876.4% | -828.9% | -1,205.3% | -1,764.2% | -5,822.7% | -6,927.2% | -11,994.3% | -34,165.5% | -3,032,164.2% | – | -12.7% | – | – | – | – | – | -2,461.3% | – | – | – | – | – | -4,761.2% | -17,003.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.